DossierENTITY

Biotech in the Balance

Coverage of Biotech in the Balance in the Nexus archive.

Earliest in view: May 28 · 18:20 UTCMost recent: May 28 · 18:20 UTC

Co-mentioned in this coverage

Recent coverage

HEALTHMay 28 · 18:20 UTCSTAT NEWS
Biotech exec Jeremy Levin on the industry’s strategic turning point
Jeremy Levin's new book 'Biotech in the Balance' addresses challenges facing the biotech industry and offers a roadmap for its future. The article also recaps recent biotech developments, including Eli Lilly's gene-editing treatment for high cholesterol and a longevity startup's funding.